Serpins (serine protease inhibitors) inhibit target proteases by forming a stable covalent complex in which the cleaved reactive site loop of the serpin is inserted into -sheet A of the serpin with concomitant translocation of the protease to the opposite of the initial binding site. Despite recent determination of the crystal structures of a Michaelis protease-serpin complex as well as a stable covalent complex, details on the kinetic mechanism remain unsolved mainly due to difficulties in measuring kinetic parameters of acylation, protease translocation, and deacylation steps. To address the problem, we applied a mathematical model developed on the basis of a suicide inhibition mechanism to the stoppedflow kinetics of fluorescence resonance energy transfer during complex formation between ␣ 1 -antitrypsin, a prototype serpin, and proteases. Compared with the hydrolysis of a peptide substrate, acylation of the protease by ␣ 1 -antitrypsin is facilitated, whereas deacylation of the acyl intermediate is strongly suppressed during the protease translocation. The results from nucleophile susceptibility of the acyl intermediate suggest strongly that the active site of the protease is already perturbed during translocation.
Serpins1 (serine protease inhibitors) are responsible for the regulation of proteolysis in many physiological processes, such as blood coagulation, fibrinolysis, compartment activation, and inflammation (1-3). They share a highly ordered structural architecture consisting of three -sheets, several ␣-helices, and the reactive site loop protruding at one pole of the molecule (4, 5). Upon binding a target protease, the serpin acylates the protease, and the resulting cleavage at P 1 -P 1 Ј bond in the reactive site loop of the serpin triggers insertion of the loop into the major -sheet, sheet A, of the serpin molecule, which accompanies translocation of the protease to the opposite pole (6 -10). Such translocation of the protease is the most striking structural change compared with the protease binding of small protease inhibitors like bovine pancreatic trypsin inhibitor (11). In the crystal structure of a serpin-protease complex the active site of the protease is distorted (10), which prevents deacylation and results in trapping the stabilized complex. One prominent feature of the serpins is that the native state is not in the most stable state but in a strained metastable state (2,4,5,12). The strain in the native conformation of the serpin appears to provide the driving force for the structural transition during the complex formation (1, 10, 13-15).Serpins inhibit target proteases by suicide substrate mechanism as depicted in Scheme 1 (6, 16), where E denotes protease; I, serpin; EI, noncovalent Michaelis complex; E-I, the acyl complex prior to translocation of protease; I*, cleaved serpin formed by deacylation of acyl linkage in E-I; E-I*, the stable covalent complex in which protease is completely translocated to the opposite pole.The stoichiometry of inhibition (SI, the number of moles of ser...